A homozygous missense variant, p.Ser166Leu in the PRPF40B gene, in a 7.7 Mb region of homozygosity in a consanguineous Turkish family with essential tremor - Report - MDSpire
Advertisement
A homozygous missense variant, p.Ser166Leu in the PRPF40B gene, in a 7.7 Mb region of homozygosity in a consanguineous Turkish family with essential tremor
Clinical Report: Identification of a homozygous missense mutation in PRPF40B
Overview
This study identifies a homozygous missense mutation, p.Ser166Leu, in the PRPF40B gene associated with essential tremor (ET) in a consanguineous Turkish family. The mutation was found to segregate with ET and is predicted to alter PRPF40B function, which has implications for understanding the genetic basis of ET.
Background
Essential tremor (ET) is a prevalent neurological disorder characterized by kinetic tremors, affecting approximately 1.33% of the global population. The high rate of consanguineous marriages in Turkey has facilitated the discovery of genetic variants associated with neurological disorders, including ET. Understanding the genetic underpinnings of ET can lead to better diagnostic and therapeutic strategies.
Data Highlights
Mutation
Location
Family Members Affected
p.Ser166Leu
Chr12: 46595701–54,330,441
4
Key Findings
A homozygous missense variant p.Ser166Leu in PRPF40B was identified in a Turkish family with ET.
The variant is located within a 7.7 Mb region of homozygosity.
Four family members were diagnosed with ET, with two also having Parkinson’s Disease.
Mutant PRPF40B showed altered localization to the nuclear membrane compared to wildtype.
In silico studies suggest the variant may impact PRPF40B function.
Clinical Implications
The identification of the PRPF40B mutation provides insight into the genetic factors contributing to essential tremor, which may aid in the development of targeted therapies. Clinicians should consider genetic counseling and testing in families with a history of ET, especially in consanguineous populations.
Conclusion
The discovery of the p.Ser166Leu mutation in PRPF40B enhances the understanding of the genetic basis of essential tremor and underscores the importance of genetic studies in familial cases of neurological disorders.
Novo Nordisk’s Parkinson’s cell therapy finds a new home at Cellular Intelligence, while base editing, prime editing, and large-insertion genome writing push forward